Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort descending
Mar
18
2016
In Re Ray Smith: Gaming Art Patents Now a Bad Bet Schwegman, Lundberg & Woessner, P.A.
Sep
8
2023
Belgian Artist Christian Silvain Wins Copyright Suit Against Sichuan Academy of Fine Arts Professor at Beijing IP Court Schwegman, Lundberg & Woessner, P.A.
Sep
28
2023
World Intellectual Property Organization Releases Global Innovation Index 2023 – China Outranks the US in Top 100 Science and Technology Clusters Schwegman, Lundberg & Woessner, P.A.
Dec
16
2013
Top Ten Intellectual Property Stories from 2013 Schwegman, Lundberg & Woessner, P.A.
Aug
2
2019
USPTO Proposes Fee Increases Across the Board Schwegman, Lundberg & Woessner, P.A.
Jan
16
2024
Chinese Utility Model Grants Down 25.5% in 2023, Invention Patent Grants Up 15.4% in Shift from Quantity to Quality Schwegman, Lundberg & Woessner, P.A.
Oct
21
2019
PTO Releases New Guidelines on Subject Matter Eligibility Schwegman, Lundberg & Woessner, P.A.
Nov
21
2019
Nuvo Pharms. v. Dr. Reddy’s Labs. – Catch 22 at the Federal Circuit? Schwegman, Lundberg & Woessner, P.A.
May
13
2014
Cotropia Study of USPTO Allowance Rate is Total Bunk – Methodology Can Easily Result in “Normalized Allowance Rates” far in Excess of 100% the Lower the Actual Allowance Rate Goes Schwegman, Lundberg & Woessner, P.A.
Apr
28
2024
China’s Beijing Internet Court Recognizes Personality Rights in Generative AI Case Schwegman, Lundberg & Woessner, P.A.
Jul
18
2016
Patent Due Diligence and Evaluation After America Invents Act Schwegman, Lundberg & Woessner, P.A.
Sep
14
2016
Federal Circuit Emphasizes Preemption and Realization as the Path to Eligibility Schwegman, Lundberg & Woessner, P.A.
Sep
20
2016
UCB v. Yeda R&D Co. – No “Safe Harbor” for Unamended Claims Schwegman, Lundberg & Woessner, P.A.
Apr
29
2020
3 Chinese Online Markets Listed in 2019 Notorious Markets List Schwegman, Lundberg & Woessner, P.A.
Nov
1
2016
More Good News for Software Patents: Amdocs (Israel) Limited v. Opnet Telecom, Inc., 2015-1180, Fed. Cir. Schwegman, Lundberg & Woessner, P.A.
May
12
2020
Guangdong Higher People’s Court Affirms 40 Million RMB Award on Utility Model Patent Schwegman, Lundberg & Woessner, P.A.
May
29
2020
China’s New Civil Law Adds Right of Publicity Schwegman, Lundberg & Woessner, P.A.
Aug
4
2014
Ignorance is Bliss – for Teva re: Structural Obviousness in Patent Cases Schwegman, Lundberg & Woessner, P.A.
Jun
15
2020
China’s State Administration for Market Regulation Releases National Plan to Combat Intellectual Property Infringement Schwegman, Lundberg & Woessner, P.A.
Jun
19
2020
China’s Copyright Administration Issues Notice on Photographic Works Schwegman, Lundberg & Woessner, P.A.
Jul
11
2020
China 2020 H1 Patent Data Indicates China Likely to Remain Top International Filer in 2020 Schwegman, Lundberg & Woessner, P.A.
Jul
16
2020
Tips For Accelerating Patent Prosecution In China Schwegman, Lundberg & Woessner, P.A.
Aug
12
2020
Beijing Intellectual Property Court Rules for Château Lafite Rothschild Winery Against Real Estate Developer in Trademark Dispute Schwegman, Lundberg & Woessner, P.A.
Sep
14
2020
China’s Patent Filings Remain Flat in August 2020 Schwegman, Lundberg & Woessner, P.A.
Oct
4
2020
China’s Supreme People’s Court Releases Guiding Opinions on Trial of Civil Cases Involving Intellectual Property Rights of E-commerce Platforms Schwegman, Lundberg & Woessner, P.A.
Oct
12
2020
Biogen v. EMD Serono – “A Nest of Limitations” Schwegman, Lundberg & Woessner, P.A.
Apr
3
2017
ChanBond Avoids Institution of Six Cisco IPR Petitions Schwegman, Lundberg & Woessner, P.A.
Oct
24
2014
AIPLA Announces New Executive Director Schwegman, Lundberg & Woessner, P.A.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins